Sponsor or institution
Clinical trials and research at Innopeutics Corporation
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Innopeutics Corporation that are recruiting, in South Korea. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Long-Term Safety and Durability of IPS101A in Parkinson's Disease
This long-term follow-up checks if IPS101A continues to be safe and whether its benefits last for people with Parkinson's who previously received the treatment.
-
IPS101A AAV gene therapy for advanced Parkinson's disease
This Phase 1 test will see if IPS101A, an AAV gene therapy, is safe and helps people aged 50–80 with advanced Parkinson's (Hoehn & Yahr 4–5) whose symptoms are not controlled by standard treatments.
Quick answers
How many clinical trials run by Innopeutics Corporation are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.